Characteristic | n (%) |
---|---|
Sex | Â |
Male | 92 (42.8%) |
Female | 123 (57.2%) |
Age | Â |
Median age, years (IQR) | 64 (50–73) |
Age \(\:\ge\:\) 65years | 107 (49.8%) |
ASA | Â |
1– Normal healthy | 31 (14.5%) |
2– Mild systemic disease | 76 (35.5%) |
3– Severe systemic disease | 77 (35.8%) |
4– Severe systemic disease that is constant threat to life 5– Moribund, not expected to survive without operation | 30 (14.0%) 1 (0.5%) |
Normal physical status– ASA 1 to 3 | 184 (85.6%) |
Poor physical status– ASA 4 to 5 | 31 (14.4%) |
Clinical Frailty Scale (CFS) | Â |
Median CFS (IQR) | 2 (2–3) |
1– Very fit | 53 (24.7%) |
2– Fit | 70 (32.6%) |
3– Managing well | 55 (25.6%) |
4– Very mild frailty | 28 (13.0%) |
5– Mild frailty | 5 (2.3%) |
6– Moderately frail | 2 (0.9%) |
7– Severely frail | 2 (0.9%) |
Not Frail– CFS 1 to 3 | 178 (82.8%) |
Frail– CFS 4 to 7 | 37 (17.2%) |
Total Psoas Index (TPI) | Â |
Median TPI, mm2/m2– Male (IQR) | 606.75 (475.48–750.30) |
Median TPI, mm2/m2– Female (IQR) Non-sarcopenic Sarcopenic | 437.12 (345.14–533.58) 161 (74.9%) 54 (25.1%) |
Overall mortality | Â |
Overall 30-day mortality Overall 90-day mortality Overall 1-year mortality | 8 (3.7%) 16 (7.4%) 24 (11.2%) |